E I Chukanova1, A S Chukanova1. 1. Pirogov Russian National Research Medical University, Moscow, Russia.
Abstract
AIM: To study the efficacy and safety of mexidol dripped intravenously (500 mg once a day) in the form of infusions for 14 days, followed by oral administration of mexidol FORTE 250 at a dose of 250 mg (1 tablet) 3 times a day for 60 days, in treatment of chronic brain ischemia in patients with hypertension and atherosclerosis. MATERIAL AND METHODS: The open observation program included 60 patients with an established diagnosis of chronic brain ischemia confirmed by neuroimaging methods. RESULTS AND CONCLUSION: The results of the study show the high efficacy and safety of sequential therapy (injections followed by tablets of mexidol FORTE 250). The treatment improves emotional and cognitive status, decreases motor disorders and severity of subjective manifestations. High adherence of patients to the therapy is shown.
AIM: To study the efficacy and safety of mexidol dripped intravenously (500 mg once a day) in the form of infusions for 14 days, followed by oral administration of mexidol FORTE 250 at a dose of 250 mg (1 tablet) 3 times a day for 60 days, in treatment of chronic brain ischemia in patients with hypertension and atherosclerosis. MATERIAL AND METHODS: The open observation program included 60 patients with an established diagnosis of chronic brain ischemia confirmed by neuroimaging methods. RESULTS AND CONCLUSION: The results of the study show the high efficacy and safety of sequential therapy (injections followed by tablets of mexidol FORTE 250). The treatment improves emotional and cognitive status, decreases motor disorders and severity of subjective manifestations. High adherence of patients to the therapy is shown.